N-[1-[2-chloro-3-(3-chloro-5-methylphenyl)-2-methylcyclopropyl]ethenyl]-3,4-dimethylaniline
C21H23Cl2N — CID 134441588
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[2-chloro-3-(3-chloro-5-methylphenyl)-2-methylcyclopropyl]ethenyl]-3,4-dimethylaniline
N-[1-[2-chloro-3-(3-chloro-5-methylphenyl)-2-methylcyclopropyl]ethenyl]-3,4-dimethylaniline (PubChem CID 134441588) has the molecular formula C21H23Cl2N and a molecular weight of 360.33 g/mol. Its IUPAC name is N-[1-[2-chloro-3-(3-chloro-5-methylphenyl)-2-methylcyclopropyl]ethenyl]-3,4-dimethylaniline.
Molecular Properties
| Compound Name | N-[1-[2-chloro-3-(3-chloro-5-methylphenyl)-2-methylcyclopropyl]ethenyl]-3,4-dimethylaniline |
|---|---|
| PubChem CID | 134441588 |
| Molecular Formula | C21H23Cl2N |
| Molecular Weight | 360.33 g/mol |
| Exact Mass | 359.12 |
| IUPAC Name | N-[1-[2-chloro-3-(3-chloro-5-methylphenyl)-2-methylcyclopropyl]ethenyl]-3,4-dimethylaniline |
| SMILES | C=C(Nc1ccc(C)c(C)c1)C1C(c2cc(C)cc(Cl)c2)C1(C)Cl |
| InChI | InChI=1S/C21H23Cl2N/c1-12-8-16(11-17(22)9-12)20-19(21(20,5)23)15(4)24-18-7-6-13(2)14(3)10-18/h6-11,19-20,24H,4H2,1-3,5H3 |
| InChIKey | WOCOJZJKHDDRAC-UHFFFAOYSA-N |
| XLogP | 6.60 |
| TPSA | 12.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 360.33 |
| LogP ≤ 5 | 6.60 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 1 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134441588 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.